Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
Content:; 1 Description -- 2 Theories and Models -- 3 Diagnosis and Treatment Indications -- 4 Treatment -- 5 Case Vignettes -- 6 Further Reading -- 7 References -- 8 Appendix: Tools and Resources
This publication represents the views and expert; opinions of an IARC Working Group on the; Evaluation of Carcinogenic Risks to Humans,; which met in Lyon, February 2013.
This publication represents the views and expert; opinions of an IARC Working Group on the; Evaluation of Carcinogenic Risks to Humans which met in Lyon (France) June 3 -10, 2014.
This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 2-9 June 2015
Table of contents:; 1. The psychosocial and physical challenges of cancer; 2. Re-visioning cognitive-behavior therapy for cancer patients; 3. Opening moves and session structure in CBT for cancer patients; 4. Creating case formulations for work with cancer patients; 5. Understanding depression in c…
Table of Contents:; Section A -- Introduction to communication studies in cancer and palliative medicine; Section B -- A core curriculum for communication skills training for oncology and palliative care; Section C -- Nursing; Section D -- A specialty curriculum for oncology; Section E -- Communica…
Table of Contents :; Introduction to advance care planning -- Overview and introduction to advance care planning -- What are the benefits of advance care planning and how do we know? -- An introduction to advance care planning: practice at the frontline -- Person-centred care: how does advance care…
This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 6-13 October 2015
This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 2-9 February 2016